Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice
Jose Manuel Carrascosa, Ignacio Garcia-Doval, Beatriz Pérez-Zafrilla, Gregorio Carretero, Francisco Vanaclocha, Esteban Daudén, Pablo De La Cueva-Dobao, Isabel Belinchón, Merce Alsina, Jose Luis López-Estebaranz, Marta Ferrán, Rosa Torrado, Raquel Rivera, Cristina Carazo, Lorena Barboza, Carlos Ferrándiz
Dive into the research topics of 'Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice'. Together they form a unique fingerprint.